The 59-year-old patient had a weakened immune system due to a kidney transplant and use of immunosuppressant drugs. He originally tested positive in December 2020 and continued to test positive through January 2022.
Researchers used a genetic sequencing of the virus to determine it was a variant from the beginning of the pandemic. Once identified, the man was given drugs known to work on that older variant.
The case, published in Clinical Infectious Diseases, highlighted the effectiveness of individualized therapies in patients with chronic COVID-19. The genome sequencing process offered results in 24 hours and allowed for appropriate, effective care.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
